Literature DB >> 750207

A chemical method for the labeling of fibrinogen with 99mTc.

O Jeghers, J Abramovici, M Jonckheer, A M Ermans.   

Abstract

A new method allowing the labelling of fibrinogen with 99mTcO4- is described. The 99mTcO4- is reduced by stannous chloride in an alkaline medium. After 1 h incubation with fibrinogen, the pH was brought down to 7.1. The study of (1) the pH of the solution, (2) the quantity of the reducer, and (3) the time of incubation allowed us to specify optimal conditions for labeling. The labeling yield varied from 91.68% plus or minus 6.05% to 95.18% plus or minus 2.13% according to the method of control used: the precipitation of fibrinogen by (NH4)2SO4 25% or thin-layer chromatography with methylethylketone as solvent. Clottable radioactivity averaged 72% plus or minus 4.43%. Column chromatography separated the tracer into two radioactive peaks. The first peak corresponded to the fibrinogen and carried 73.36% plus or minus 5.8% of the total radioactivity. The total recovered radioactivity amounted to 89.86% plus or minus 8.07%. Spectroscopic clottability was 88.23% plus or minus 2.42%. The in vivo stability of the labeling and the molecule was followed for 24 h after intravenous injection. If the radioactivity measured in the 5 min sample was considered to equal 100%, the 24 h sample averaged 32.71% plus or minus 3.25%, of which 85.68% plus or minus 2.92% was recovered in the clot. In conclusion, this method enabled us to obtain a stable tracer that we used for routine investigations in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 750207     DOI: 10.1007/bf00251631

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  16 in total

1.  [99MTechnetium-fibrinogen labeling using electrolytic zircuronium release].

Authors:  H P Hebestreit; C Pryss
Journal:  Nucl Med (Stuttg)       Date:  1975-06-30

2.  LABELLING OF HUMAN FIBRINOGEN WITH 131-I BY ELECTROLYTIC IODINATION.

Authors:  U ROSA; G A SCASSELLATI; F PENNISI
Journal:  Biochim Biophys Acta       Date:  1964-06-08

3.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

4.  Behaviour of 14C- and 131I-labelled plasma proteins in the rat.

Authors:  R M CAMPBELL; D P CUTHBERTSON; C M MATTHEWS; A S MCFARLANE
Journal:  Int J Appl Radiat Isot       Date:  1956-07

5.  Preparation and in vitro properties of 99mTc-fibrinogen.

Authors:  J F Harwig; S S Harwig; L D Wells; M J Welch
Journal:  Int J Appl Radiat Isot       Date:  1976-01

6.  Technetium-99m-human fibrinogen.

Authors:  D W Wong; F S Mishkin
Journal:  J Nucl Med       Date:  1975-05       Impact factor: 10.057

7.  A rapid index of free activity in preparations of 99mTc-albumin.

Authors:  M Lamson; R J Callahan; F P Castronovo; K A McKusick; M S Potsaid
Journal:  J Nucl Med       Date:  1974-11       Impact factor: 10.057

8.  Thrombin clotting time--a more sensitive indicator of denatured fibrinogen than clottability.

Authors:  B Ly; H C Godal; P Kierulf
Journal:  Haemostasis       Date:  1972

9.  The processes involved in the binding of technetium-99m to human serum albumin.

Authors:  M J Williams; T Deegan
Journal:  Int J Appl Radiat Isot       Date:  1971-12

10.  Use of Fe(II) or Sn(II) alone for technetium labeling of albumin.

Authors:  M S Lin; H S Winchell; B A Shipley
Journal:  J Nucl Med       Date:  1971-05       Impact factor: 10.057

View more
  5 in total

1.  The interpretation of phlebograms using fibrinogen labeled with 99 mTc.

Authors:  M H Jonckheer; J Abramovici; O Jeghers; J P Dereume; M Goldstein
Journal:  Eur J Nucl Med       Date:  1978

2.  99mTc-fibrinogen as a thrombus-imaging agent.

Authors:  T I HAle; A Jucker
Journal:  Eur J Nucl Med       Date:  1978

3.  67 Ga-labeled human fibrinogen: a new promising thrombus imaging agent.

Authors:  Y Ohmomo; A Yokoyama; J Suzuki; H Tanaka; K Yamamoto; K Horiuchi; Y Ishii; K Torizuka
Journal:  Eur J Nucl Med       Date:  1982

4.  In vitro properties and in vivo behavior of technetium-99m labeled fibrinogens.

Authors:  Y Karube; S Ito; K Katsuno; J Takata
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

5.  An experimental study of deep-vein thrombosis using 99mTc-fibrinogen.

Authors:  S Higashi; Y Kuniyasu
Journal:  Eur J Nucl Med       Date:  1984
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.